Okami Medical

Executive Summary

Okami Medical is a privately held medical device company based in Irvine, CA, focused on developing innovative devices for peripheral vessel occlusion. Founded in 2017, the company aims to address the evolving needs of patients and physicians with versatile and intuitive products. While specific financial and pipeline details are not publicly disclosed, Okami Medical operates in the high-growth peripheral vascular intervention market. The company's technology has the potential to improve outcomes in embolization procedures, targeting conditions such as hemorrhage, tumors, and vascular malformations. With a strong IP portfolio and a seasoned management team, Okami Medical is well-positioned to capture market share from established players. However, as a private company, visibility into operations is limited, and execution risk remains. The company's success hinges on obtaining regulatory clearances and commercial traction in a competitive landscape.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for Lead Product70% success
• Q2 2027First-in-Human Clinical Study Initiation60% success
• Q3 2026Series B Funding Round Closing80% success